Bayer restructures US glyphosate business into Ruveon unit and seeks tariffs on Chinese imports

Bayer announced that its U.S. glyphosate operations will be consolidated under a newly created subsidiary, Ruveon LLC, based in St. Louis, Missouri. The unit will manage pricing, sales, production and logistics for the Roundup‑type herbicide in the United States as part of Bayer’s five‑year Crop Science restructuring plan.

On the same day, Bayer and its Monsanto affiliate filed a petition with the U.S. International Trade Commission and the Department of Commerce requesting antidumping and countervailing duties on glyphosate imported from China. The petition alleges dumping margins of 68% to more than 440% and cites a sharp rise in Chinese export volumes that it says is harming the domestic market. Trade groups representing corn, soybean and wheat growers warned the measures would raise herbicide costs for farmers. National Corn Growers Association president Jed Bower said, "They are taking this step purely for the benefit of the company and its shareholders, at the expense of the American farmer."

The restructuring follows a recent U.S. Supreme Court ruling that shielded Bayer from state‑level lawsuits over alleged cancer risks of glyphosate, as well as a $7.25 billion settlement of Roundup litigation. Bayer described the creation of Ruveon as "a significant milestone in implementing our five‑year program," according to Crop Science North America leader Brian Naber.